Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Vadgama JV"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 33
Tytuł:
Inflammatory Cytokines Associated with Obesity, Type-2 Diabetes, and Hypertension Exacerbate Breast Cancer Risk in Underserved African American and Latin American Women.
Autorzy:
Wu Y; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Karapetyan E; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Dutta P; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Shaheen M; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Vadgama JV; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2024 Mar 15; Vol. 13 (6). Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12 , 1918.
Autorzy:
Wu Y; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, 1731 East 120th Street, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Sarkissyan M; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, 1731 East 120th Street, Los Angeles, CA 90059, USA.
Ogah O; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, 1731 East 120th Street, Los Angeles, CA 90059, USA.
Kim J; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, 1731 East 120th Street, Los Angeles, CA 90059, USA.
Vadgama JV; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, 1731 East 120th Street, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2024 Mar 01; Vol. 16 (5). Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Published Erratum
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice.
Autorzy:
Hao Q; Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Henning SM; Center for Human Nutrition, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Magyar CE; Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Said J; Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Zhong J; VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.; Department of Internal Medicine, School of Medicine, University of California, Riverside, CA 92521, USA.
Rettig MB; Departments of Medicine and Urology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Vadgama JV; Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Wang P; Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; Center for Human Nutrition, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2024 Jan 14; Vol. 14 (1). Date of Electronic Publication: 2024 Jan 14.
Typ publikacji:
Journal Article
MeSH Terms:
Furans*
Lignans*/pharmacology
Lignans*/therapeutic use
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/prevention & control
Animals ; Male ; Mice ; Chemoprevention ; Mice, Knockout ; Phosphatidylinositol 3-Kinases ; Prostate/drug effects ; Quercetin/pharmacology ; Quercetin/therapeutic use ; Tensins ; PTEN Phosphohydrolase/genetics ; PTEN Phosphohydrolase/metabolism ; Tea
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Correction: Dutta et al. Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer. Cancers 2020, 12 , 1317.
Autorzy:
Dutta P; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Paico K; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Gomez G; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Wu Y; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, The University of California at Los Angeles, Los Angeles, CA 90059, USA.
Vadgama JV; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, The University of California at Los Angeles, Los Angeles, CA 90059, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Dec 19; Vol. 16 (1). Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:
Published Erratum
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Squalamines in Blockade of Tumor-Associated Angiogenesis and Cancer Progression.
Autorzy:
Sterling C Jr; Division of Cancer Research and Training, Charles Drew University School of Medicine and Science, Los Angeles, CA 90059, USA.
Márquez-Garbán D; Division of Hematology-Oncology, Department of Medicine, UCLA David Geffen School of Medicine and UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, USA.
Vadgama JV; Division of Cancer Research and Training, Charles Drew University School of Medicine and Science, Los Angeles, CA 90059, USA.; Division of Hematology-Oncology, Department of Medicine, UCLA David Geffen School of Medicine and UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, USA.
Pietras RJ; Division of Cancer Research and Training, Charles Drew University School of Medicine and Science, Los Angeles, CA 90059, USA.; Division of Hematology-Oncology, Department of Medicine, UCLA David Geffen School of Medicine and UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Oct 21; Vol. 14 (20). Date of Electronic Publication: 2022 Oct 21.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies.
Autorzy:
Hao Q; Division of Cancer Research and Training, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Wu Y; Division of Cancer Research and Training, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Vadgama JV; Division of Cancer Research and Training, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Wang P; Division of Cancer Research and Training, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2022 Sep 16; Vol. 12 (9). Date of Electronic Publication: 2022 Sep 16.
Typ publikacji:
Journal Article; Review; Systematic Review; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/pathology
Apoptosis ; Hormones ; Humans ; Male ; Neovascularization, Pathologic/drug therapy ; Phytochemicals/pharmacology ; Phytochemicals/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tumor-Derived Exosomes in Tumor-Induced Immune Suppression.
Autorzy:
Hao Q; Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Wu Y; Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Wu Y; Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Wang P; Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Vadgama JV; Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jan 27; Vol. 23 (3). Date of Electronic Publication: 2022 Jan 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunosuppression Therapy*
Exosomes/*metabolism
Neoplasms/*metabolism
Animals ; Humans ; Ligands ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Models, Biological
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Elevated Baseline Serum PD-L1 Level May Predict Poor Outcomes from Breast Cancer in African-American and Hispanic Women.
Autorzy:
Wu Y; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Dutta P; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Clayton S; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
McCloud A; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Vadgama JV; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2022 Jan 06; Vol. 11 (2). Date of Electronic Publication: 2022 Jan 06.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers.
Autorzy:
Wu Y; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, 1731 East 120th Street, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Sarkissyan M; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, 1731 East 120th Street, Los Angeles, CA 90059, USA.
Ogah O; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, 1731 East 120th Street, Los Angeles, CA 90059, USA.
Kim J; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, 1731 East 120th Street, Los Angeles, CA 90059, USA.
Vadgama JV; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, 1731 East 120th Street, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Jul 16; Vol. 12 (7). Date of Electronic Publication: 2020 Jul 16.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CCL2/CCR2 signaling in cancer pathogenesis.
Autorzy:
Hao Q; Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA, 90059, USA. .; David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA. .
Vadgama JV; Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA, 90059, USA. .; David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA. .
Wang P; Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA, 90059, USA. .; David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA. .; Center for Human Nutrition, University of California, Los Angeles, CA, 90095, USA. .
Pokaż więcej
Źródło:
Cell communication and signaling : CCS [Cell Commun Signal] 2020 May 29; Vol. 18 (1), pp. 82. Date of Electronic Publication: 2020 May 29.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Review; Video-Audio Media
MeSH Terms:
Chemokine CCL2/*physiology
Inflammation/*metabolism
Prostatic Neoplasms/*metabolism
Receptors, CCR2/*physiology
Animals ; Humans ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer.
Autorzy:
Dutta P; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Paico K; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Gomez G; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Wu Y; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, the University of California at Los Angeles, Los Angeles, CA 90059, USA.
Vadgama JV; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, the University of California at Los Angeles, Los Angeles, CA 90059, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 May 21; Vol. 12 (5). Date of Electronic Publication: 2020 May 21.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status.
Autorzy:
Keung MY; Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Wu Y; Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; David Geffen UCLA School of Medicine, Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Badar F; Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Vadgama JV; Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.; David Geffen UCLA School of Medicine, Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2020 Mar 30; Vol. 9 (4). Date of Electronic Publication: 2020 Mar 30.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers.
Autorzy:
Keung MYT; Division of Cancer Research and Training, Charles Drew University, Los Angeles, CA 90059-2518, USA. .
Wu Y; Division of Cancer Research and Training, Charles Drew University, Los Angeles, CA 90059-2518, USA. .; David Geffen School of Medicine, Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, CA 90095, USA. .
Vadgama JV; Division of Cancer Research and Training, Charles Drew University, Los Angeles, CA 90059-2518, USA. .; David Geffen School of Medicine, Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, CA 90095, USA. .
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2019 Mar 30; Vol. 8 (4). Date of Electronic Publication: 2019 Mar 30.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Utilization of NGS technologies to investigate transcriptomic and epigenomic mechanisms in trastuzumab resistance.
Autorzy:
Nava M; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, USA.; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
Dutta P; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, USA.
Farias-Eisner R; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
Vadgama JV; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, USA. .; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA. .
Wu Y; Division of Cancer Research and Training, Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, USA. .; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Mar 26; Vol. 9 (1), pp. 5141. Date of Electronic Publication: 2019 Mar 26.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
High-Throughput Nucleotide Sequencing*
Drug Resistance, Neoplasm/*genetics
Epigenesis, Genetic/*drug effects
Gene Expression Regulation, Neoplastic/*drug effects
Neoplasms/*genetics
Transcriptome/*drug effects
Trastuzumab/*pharmacology
Cell Line, Tumor ; Drug Resistance, Neoplasm/drug effects ; Humans ; Neoplasms/drug therapy ; Neoplasms/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 33

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies